MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

ORAGENICS INC (OGEN)

ORAGENICS INC (OGEN)

|||

Balance Sheets Overview

Debt to Asset Ratio
33.17%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Common stock, 0.001 par value 35...
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
3,864,184
6,107,078
4,399,726
11,403,766
Short-term investments
-
-
4,000,000
-
Interest receivable
-
-
53,082
-
Prepaid expenses and other current assets
1,628,317
1,382,558
1,614,956
1,301,778
Total current assets
5,492,501
7,489,636
10,067,764
12,705,544
Total assets
5,492,501
7,489,636
10,067,764
12,705,544
Accounts payable and accrued expenses
1,821,867
1,251,744
1,559,011
2,479,272
Short-term notes payable, net of debt issuance costs
-
56,134
227,348
394,836
Total liabilities
1,821,867
1,307,878
1,786,359
2,874,108
Common stock, 0.001 par value 350,000,000 shares authorized 4,511,957 and 4,271,529 shares issued and outstanding at june 30, 2026, and december 31, 2025, respectively
4,512
4,375
4,271
4,127
Additional paid-in capital
235,024,731
235,007,285
234,905,793
234,169,098
Accumulated deficit
-231,358,609
-228,829,902
-226,628,659
-224,341,789
Total stockholders equity
3,670,634
6,181,758
8,281,405
9,831,436
Total liabilities and stockholders equity
5,492,501
7,489,636
10,067,764
12,705,544
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$3,864,184 (95.78%↑ Y/Y)Prepaid expenses andother current assets$1,628,317 (881.13%↑ Y/Y)Total current assets$5,492,501 (156.69%↑ Y/Y)Total assets$5,492,501 (156.69%↑ Y/Y)Total liabilities andstockholders equity$5,492,501 (156.69%↑ Y/Y)Total stockholdersequity$3,670,634 (272.52%↑ Y/Y)Total liabilities$1,821,867 (-57.31%↓ Y/Y)Accumulated deficit-$231,358,609 (-4.56%↓ Y/Y)Additional paid-in capital$235,024,731 (7.25%↑ Y/Y)Accounts payable andaccrued expenses$1,821,867 (43.75%↑ Y/Y)Common stock, 0.001 parvalue 350,000,000...$4,512 (448.24%↑ Y/Y)